agilon health to Host Virtual Investor Event on November 17, 2026
agilon health announced it will host a virtual investor event titled "Driving Performance At Scale: The agilon Framework" on November 17, 2026.
Stocks · News reference
Evercore ISI Group Raises Price Target for agilon health
Evercore ISI Group maintained its "In-Line" rating on agilon health and increased its price target from $95 to $105.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Evercore ISI Group Maintains In-Line on Agilon Health, Raises Price Target to $105
agilon health Reports Third-Quarter 2026 Financial Results
agilon health, inc. reported third-quarter 2026 revenue of $1.52 billion and net income of $35 million, exceeding analyst expectations and raising its full-year 2026 guidance.
agilon health, inc. Reports Third Quarter 2026 Financial Results
agilon health, inc. announced its financial results for the third quarter ended September 30, 2026, reporting revenue of $1.52 billion.
Global Value-Based Healthcare Market is Predicted to Cross USD 60 Billion by 2034 | DelveInsight
The value-based healthcare market is experiencing robust growth, projected to reach USD 62 billion by 2034 from USD 16.5 billion in 2025, with a CAGR of ~16%. The shift from fee-for-service to outcome-based payment models is driven by rising healthcare costs, chronic disease burden, and government reimbursement reforms. North America dominates with 72% market share, while Asia-Pacific is expected to record the fastest growth. Key players include Optum, Humana, Evolent Health, Agilon Health, and Privia Health.
This Ulta Beauty Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Tuesday
Analysts upgraded Pentair, Agilon Health, Etsy, Radiant Logistics and Ulta Beauty, raising or setting new price targets.